Allergy, Asthma and Immunology

A blog that publishes updates and open access scientific papers about allergy, asthma and immunology. Editor: Juan Carlos Ivancevich, MD. Specialist in Allergy & Immunology

Menu

  • Home
  • Allergy OA
  • Dermatology OA
  • Otorhinolaryngology OA
  • Pediatrics OA
  • Respiratory Medicine OA
  • Contact

May 11, 2023

Lung-specific MCEMP1 functions as an adaptor for KIT to promote SCF-mediated mast cell proliferation

Choi YJ, Yoo JS, Jung K, Rice L, Kim D, Zlojutro V, Frimel M, Madden E, Choi UY, Foo SS, Choi Y, Jiang Z, Johnson H, Kwak MJ, Kang S, Hong B, Seo GJ, Kim S, Lee SA, Amini-Bavil-Olyaee S, Maazi H, Akbari O, Asosingh K, Jung JU.  Nat Commun. 2023 Apr 11;14(1):2045. doi: 10.1038/s41467-023-37873-3.

Abstract

Lung mast cells are important in host defense, and excessive proliferation or activation of these cells can cause chronic inflammatory disorders like asthma. Two parallel pathways induced by KIT–stem cell factor (SCF) and FcεRI–immunoglobulin E interactions are critical for the proliferation and activation of mast cells, respectively. Here, we report that mast cell-expressed membrane protein1 (MCEMP1), a lung-specific surface protein, functions as an adaptor for KIT, which promotes SCF-mediated mast cell proliferation.

MCEMP1 deficiency ameliorates lung compliance and airflow in OVA-induced chronic asthma.
MCEMP1 elicits intracellular signaling through its cytoplasmic immunoreceptor tyrosine-based activation motif and forms a complex with KIT to enhance its autophosphorylation and activation. Consequently, MCEMP1 deficiency impairs SCF-induced peritoneal mast cell proliferation in vitro and lung mast cell expansion in vivo. Mcemp1-deficient mice exhibit reduced airway inflammation and lung impairment in chronic asthma mouse models. This study shows lung-specific MCEMP1 as an adaptor for KIT to facilitate SCF-mediated mast cell proliferation.


Download PDF

Publicado por ivancev@gmail.com en 9:47 AM
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Newsletter

Get new posts by email:
Powered by follow.it

Search This Blog

Translations

ORCID Juan C. Ivancevich

ORCID iD iconhttps://orcid.org/0000-0001-8713-6258

Blog Archive

Popular posts

  • Systemic Therapy for Atopic Dermatitis: Choosing Biologics or Janus Kinase Inhibitors for Children and Adults
    Scholl IM, Drucker AM, Flohr C, Gerbens LAA.  J Allergy Clin Immunol Pract. 2026 Feb;14(2):344-359. doi: 10.1016/j.jaip.2025.10.052. Abstrac...
  • Desensitisation to cow’s milk, following partially or extensively hydrolysed formulae feeding regimens, in infants with allergy to cow’s milk: the DREAM RCT Synopsis (The DREAM study)
    Guibas G, Brayshaw E, Brown M et al.    Efficacy Mech Eval 2026. https://doi.org/10.3310/GJGG7715 Background Immunoglobulin E-mediated (imme...
  • Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments
    Vieira RJ, Sousa-Pinto B, Bousquet J et al.  Allergy. 2026 Mar 24. doi: 10.1111/all.70305.  Abstract Background: Oral and ocular medication...

Twitter

Tweets by @Aller_MD

Interesting Links

  • World Allergy Organization
  • Latin American Society of Allergy, Asthma & Immunology
  • Interasma
  • European Academy of Allergy & Immunology
  • American College of Allergy, Asthma & Immunology
  • American Academy of Allergy, Astma & Immunology
  • TRIP Database
  • Ga2len
Juan Carlos Ivancevich, MD. Powered by Blogger.